Our news
![First promising clinical results with Lipitear™ for NK, Neurotrophic Keratitis treament](https://assets-global.website-files.com/61a832c8109ca60ce77ee795/61e6e8af6cae29a7c0d5359d_pexels-rodnae-productions-7020545-750x420.jpeg)
Jan
18
Clinical Data
First promising clinical results with Lipitear™ for NK, Neurotrophic Keratitis treament
Lipitear™ was found helpful in treating neurotrophic keratitis (NK).Pr. Arieh Salomon and Pr. Naphtali Savion published on March 2021 a poster on the Management of Neurotrophic Keratitis with Phospholipid/Triglyceride Based Lipid Emulsion. “Lipitear™
![ESCRS 2020 Poster – CLASS: surgical technique and preliminary results](https://assets-global.website-files.com/61a832c8109ca60ce77ee795/61e6e7dbadb4424cdd5001c8_escrs.png)
Jan
18
Clinical Data
ESCRS 2020 Poster – CLASS: surgical technique and preliminary results
Poster Details First Author: A.Lopez-Vazquez SPAIN Co Author(s): C. Fernández Alcalde A. Ramos Castrillo R. Larga Hontoria J. Vila Arteaga J. Larosa Poves C. Lavín Dapena Abstract Details Purpose:To evaluate the efficacy
Flash Info
July is Dry Eye Awareness Month, so IOPtima is proud to present the first ads for the only preservative-free lipid-based eye drops, LIPITEAR™ MULTI, that are currently already available in Israel.
We’re pleased to announce that we have appointed Eran Kaplan as new Chief Executive Officer of IOPtima
New article - Why is Dr Roberto Anaya a fan of IOPtima’s iLid CO2 laser for blepharoplasty?